Beta-2-Glycoprotein IgM

What is Beta-2-Glycoprotein IgM?

An antibody isotype in the antiphospholipid panel used to evaluate clotting-related autoimmune conditions.

Beta-2-glycoprotein I is a protein that normally helps regulate blood clotting, and antibodies against it are one of three markers, along with anticardiolipin antibodies and lupus anticoagulant, used to evaluate antiphospholipid syndrome. The IgM isotype sometimes fluctuates more with acute illness and may be somewhat less specific for clotting risk than IgG, though it is still part of the standard testing panel. It is often ordered when someone has experienced unexplained blood clots, recurrent pregnancy loss, or has an underlying autoimmune condition such as lupus. A positive result is typically confirmed with repeat testing weeks later, since transient positives can occur, for example after infection. As with other antiphospholipid markers, this result is one piece of a broader clinical and laboratory picture rather than a stand-alone diagnosis.

Tests often checked alongside this

• Beta-2-Glycoprotein IgA — a related isotype tested in the same panel
• Beta-2-Glycoprotein IgG — the isotype most strongly linked to clotting risk
• Cardiolipin Ab IgA, IgG, and IgM — the other main antiphospholipid antibodies
• ANA Pattern and ANA Titer — often checked in suspected lupus overlap

How this can show up in how you look and feel

• May be associated with a history of unexplained blood clots
• May be associated with recurrent pregnancy loss
• May be associated with migraine-like headaches
• May be associated with a mottled skin pattern (livedo reticularis)

What can affect this marker

• Sex
• Pregnancy
• Medications
• Infection
• Lab variability, including the need for repeat confirmatory testing

What to track over time

• Whether a positive result persists on repeat testing weeks later
• How results align with cardiolipin antibody and lupus anticoagulant testing
• Whether monitoring is considered before or during pregnancy

What to ask your doctor

• Does this result need to be repeated to confirm a persistent finding?
• How does this relate to my cardiolipin antibody results?
• Could this affect pregnancy planning or management?
• Should I be evaluated for antiphospholipid syndrome more broadly?

This glossary entry is for informational purposes only and is not a substitute for professional medical advice. Read our Terms of Use.